Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Mitokondriel Metabolisme og Oxidativ Stress i Funktion af Fysisk Træning og Ernæringsvejledning i T2DM (MITOX)

10. september 2026 opdateret af: University of Cadiz

Mitokondriel Metabolisme og Oxidativ Stress i Funktion af Typen af Fysisk Træning og Ernæringsvejledning ved Type 2 Diabetes Mellitus

Formålet med denne randomiserede kontrollerede undersøgelse er at lære om virkningerne af forskellige aerobe træningsformer (moderat-intensitets kontinuerlig træning (MICT) og høj-intensitets intervaltræning (HIIT)) og kost på mitochondrielle egenskaber og oxidativ stress hos patienter med type 2-diabetes (T2D). Den vil også undersøge de forskellige virkninger af disse interventioner hos mænd og kvinder. De vigtigste spørgsmål, den sigter mod at besvare, er:

  • Hvad er den isolerede og kombinerede effekt af disse træningsformer og kost? Er der en overlegen tilgang til mitochondrial metabolisme og oxidativ stress hos patienter med T2D?
  • Er der et køns-specifikt bedste kombinationsvalg for disse forskellige interventioner?
  • Er der nogen sammenhæng mellem trænings- og kostinducerede ændringer i mitochondrielle egenskaber og oxidativ stress og andre sundhedsrelaterede resultater såsom kropsammensætning eller insulinfølsomhed?

For at besvare disse spørgsmål designede forskerne en to-faktor undersøgelse. Den ene faktor var træning, som havde tre niveauer (MICT, HIIT og den inaktive (INACT) tilstand). Den anden faktor var kost, med to niveauer (Kost (D) og ingen kost (ND)). Deltagerne blev derfor tilfældigt tildelt til 6 grupper: INACT-ND, INACT-D, MICT-ND, MICT-D, HIIT-ND og HIIT-D.

Deltagerne udførte:

  • Gennemgik en 12-ugers intervention inden for rammerne af deres gruppes betingelser
  • Besøgte forskningsgruppens faciliteter tre gange om ugen, hvis de var i en træningsgruppe, eller en gang hver anden uge, hvis de var i en kostgruppe.

Studieoversigt

Detaljeret beskrivelse

Dette er en randomiseret kontrolleret undersøgelse udført i provinsen Cádiz (Spanien). I alt 146 deltagere blev inkluderet i undersøgelsen og gennemgik baseline- og post-interventionsbestemmelser af studieudfaldene. Lige efter baseline-bestemmelsen blev deltagerne tilfældigt tildelt til en af de tidligere nævnte studiegrupper. Randomiseringsprocessen var stratificeret efter køn, hvilket betyder, at cirka 50% af deltagerne i hver gruppe var kvinder. Alle deltagere modtog detaljeret skriftlig og mundtlig information om studieformålene, procedurerne, fordelene og potentielle risici, før de gav skriftlig informeret samtykke. Denne undersøgelse overholdt principperne i Helsingfors-erklæringen og blev godkendt af den provinsielle forskningsetiske komité i Cádiz og den koordinerende komité for biomedicinsk forskningsetik i Andalusien (registreringsnummer 92.21; PEIBA-nummer 1026-N-21; interne koder SICEIA-2025-001870 og SICEIA-2025-000778).

Ved både baseline og post-intervention blev deltagerne planlagt om morgenen efter en nattefastning på 8-10 timer. De blev instrueret i at opretholde deres sædvanlige livsstil, afholde sig fra alkohol og koffein i 24 timer og undgå anstrengende fysisk aktivitet i 72 timer før testen. Procedurerne omfattede kropskompositionsvurdering gennem elektrisk bioimpedans, en biopsi af musculus vastus lateralis, fastende blodprøvetagning og en oral glukosetolerance test (OGTT) ved indtagelse af 75 gram glukose og blodprøver efter 30, 60, 90, 120, 150 og 180 minutter efter indtagelsen. Den samme protokol blev gentaget efter de 12 ugers intervention, hvor motionsgrupperne afsluttede deres sidste træningssession mindst 72 timer før post-interventionsvurderingerne.

Undersøgelsestype

Interventionel

Tilmelding (Faktiske)

146

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

    • Cádiz
      • Puerto Real, Cádiz, Spanien, 11510
        • Science of Education Faculty

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

  • Voksen
  • Ældre voksen

Tager imod sunde frivillige

Ingen

Beskrivelse

Inklusionskriterier:

  • Diagnose af T2D eller prædiabetes (glykeret hæmoglobin ≥ 5,7%)
  • Ingen historie for misbrug (tobak, alkohol eller andre stoffer).
  • Body mass index >25 kg/m², opretholder de sædvanlige kostvaner med stabil kropsvægt i mindst 6 måneder
  • Stabil fysisk aktivitet og medicinregime i mindst 6 måneder
  • Ikke insulinafhængig
  • Fravær af skade, sygdom, handicap eller andre kendte medicinske tilstande, der kan påvirke evnen til at deltage succesfuldt i fysiske træningstests
  • Fravær af svulster og kræftsygdom
  • Fravær af andre patologier, der kan påvirke studieudfaldene.
  • Ikke under medicinregime, der kan påvirke studieudfaldene.
  • At kunne forstå kommunikation på spansk eller engelsk.
  • Ikke gravid

Eksklusionskriterier:

  • Manglende deltagelse i mere end 2 på hinanden følgende eller i alt 4 sessioner af ernæringsintervention.
  • Manglende deltagelse i mere end 4 på hinanden følgende eller i alt 6 sessioner af fysisk træning.
  • Alvorlig skade
  • Frivillig tilbagetrækning
  • Forøget dosis af diabetesmedicin

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Behandling
  • Tildeling: Randomiseret
  • Interventionel model: Parallel tildeling
  • Maskning: Dobbelt

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Ingen indgriben: ND-INAKTIV
Deltagere, som ikke modtog hverken ernæringsmæssig intervention eller motionsprogram.
De blev instrueret i at opretholde deres normale livsstilsvaner vedrørende fysisk aktivitet og kost.
Aktiv komparator: Moderat intensitet kontinuerlig træning (ND-MICT)
Deltagere, der ikke modtog ernæringsmæssig intervention, men som var tilmeldt et moderat intensivt kontinuerligt træningsprogram.

Deltagere tildelt MICT gennemførte 3 ugentlige sessioner, med 1-2 dages hvile mellem sessioner, på en cykelergometer i 12 uger.

MICT bestod af 50 minutters kontinuerlig pedaling med en intensitet på cirka 10 % over lactattærsklen, med en kadence mellem 60-80 rpm. Træningsbelastning (TL) blev øget med 10%, hvis disse to betingelser var opfyldt: 1) ingen stigning på mindst 2 slag i hjertefrekvens fra minut 20 til minut 40 af træningssessionen, og 2) lactatniveauer under 2 mmol/L i minut 48 af sessionen. TL for den første session blev bestemt af en justeringstest bestående af en inkrementel test med fem på hinanden følgende 10-minutters faser ved en konstant kadence (60-80 RPM) fra 90% til 130% af den ventilatoriske tærskelkraft, beregnet fra tidligere udførte FatOx-testdata, med 10% stigninger i hvert trin. TL blev bestemt af den fase, hvor HR steg med ≥ 3 slag mellem faser og blodlactatniveauer steg med ≥ 1 mmol/L fra den foregående fase.

Aktiv komparator: Højintensiv intervaltræning (ND-HIIT)
Deltagere, der ikke modtog ernæringsmæssig intervention, men var tilmeldt et højintensitetsintervaltræningsprogram.

Participants assigned to the HIIT completed 3 weekly sessions, with 1-2 days of rest between sessions, on a cycle ergometer for 12 weeks.

The training load (TL) was determined from an incremental test until volitional exhaustion with one-minute work intervals (from 85% to 165% of maximal power output from a previously performed VO2max test [Wmax] and with 10% increments) separated by 1.5-minute rest periods (at 20% Wmax).

The program consisted of a 3 minutes warm-up with the first 2 minutes at 20% and last minute at 40% of the TL, followed by 10 series of 1 min duration at 90% of TL, with 1 minute of rest between sets at 20% of TL and ending with 2 minutes of cool-down at 20% of TL (estimated total time of the session: 25 minutes). A 5% increase in workload was applied when, for two consecutive sessions, the first three intervals failed to exceed 85%, and at least five did not reach 90% of maximal HR. Participants were asked to maintain a cadence above 80RPM.

Aktiv komparator: Ernæringsmæssig intervention (D-INACT)
Deltagere, der modtog ernæringsmæssig intervention men ikke et motionsprogram.
The nutritional intervention was conducted through biweekly (± 3 days) in-person consultations with a nutritionist or dietitian. Firstly, the patient's diet was analyzed. Then, participants were guided to follow a mildly calorie-restricted diet (-250-500 kcal/day deficit), with the primary goal of achieving a 5 % reduction in body weight and reducing blood glucose levels. Meal plans were created using Nutrium® software , personalized to each participant's lifestyle and food preferences, and reviewed at each biweekly consultation. The dietary plan included at least 4 or 5 meals per day, ensuring a well-distributed intake of carbohydrates, a balanced distribution of macro- and micronutrients, and the inclusion of foods rich in prebiotics and probiotics. Moreover, some suggestions about the combination of foods and culinary techniques were provided. Only one session through the intervention was allowed to be attended telephonically.
Eksperimentel: Ernæringsmæssig Intervention Moderat-Intensiv kontinuerlig træning (D-MICT)
Deltagere, der modtog ernæringsmæssig intervention og var tilmeldt et moderat intensivt kontinuerligt træningsprogram.

Deltagere tildelt MICT gennemførte 3 ugentlige sessioner, med 1-2 dages hvile mellem sessioner, på en cykelergometer i 12 uger.

MICT bestod af 50 minutters kontinuerlig pedaling med en intensitet på cirka 10 % over lactattærsklen, med en kadence mellem 60-80 rpm. Træningsbelastning (TL) blev øget med 10%, hvis disse to betingelser var opfyldt: 1) ingen stigning på mindst 2 slag i hjertefrekvens fra minut 20 til minut 40 af træningssessionen, og 2) lactatniveauer under 2 mmol/L i minut 48 af sessionen. TL for den første session blev bestemt af en justeringstest bestående af en inkrementel test med fem på hinanden følgende 10-minutters faser ved en konstant kadence (60-80 RPM) fra 90% til 130% af den ventilatoriske tærskelkraft, beregnet fra tidligere udførte FatOx-testdata, med 10% stigninger i hvert trin. TL blev bestemt af den fase, hvor HR steg med ≥ 3 slag mellem faser og blodlactatniveauer steg med ≥ 1 mmol/L fra den foregående fase.

The nutritional intervention was conducted through biweekly (± 3 days) in-person consultations with a nutritionist or dietitian. Firstly, the patient's diet was analyzed. Then, participants were guided to follow a mildly calorie-restricted diet (-250-500 kcal/day deficit), with the primary goal of achieving a 5 % reduction in body weight and reducing blood glucose levels. Meal plans were created using Nutrium® software , personalized to each participant's lifestyle and food preferences, and reviewed at each biweekly consultation. The dietary plan included at least 4 or 5 meals per day, ensuring a well-distributed intake of carbohydrates, a balanced distribution of macro- and micronutrients, and the inclusion of foods rich in prebiotics and probiotics. Moreover, some suggestions about the combination of foods and culinary techniques were provided. Only one session through the intervention was allowed to be attended telephonically.
Eksperimentel: Ernæringsmæssig Intervention Højintensiv intervaltræning (D-HIIT)
Deltagere, der modtog ernæringsmæssig intervention og blev tilmeldt et højintensivt intervaltræningsprogram.
The nutritional intervention was conducted through biweekly (± 3 days) in-person consultations with a nutritionist or dietitian. Firstly, the patient's diet was analyzed. Then, participants were guided to follow a mildly calorie-restricted diet (-250-500 kcal/day deficit), with the primary goal of achieving a 5 % reduction in body weight and reducing blood glucose levels. Meal plans were created using Nutrium® software , personalized to each participant's lifestyle and food preferences, and reviewed at each biweekly consultation. The dietary plan included at least 4 or 5 meals per day, ensuring a well-distributed intake of carbohydrates, a balanced distribution of macro- and micronutrients, and the inclusion of foods rich in prebiotics and probiotics. Moreover, some suggestions about the combination of foods and culinary techniques were provided. Only one session through the intervention was allowed to be attended telephonically.

Participants assigned to the HIIT completed 3 weekly sessions, with 1-2 days of rest between sessions, on a cycle ergometer for 12 weeks.

The training load (TL) was determined from an incremental test until volitional exhaustion with one-minute work intervals (from 85% to 165% of maximal power output from a previously performed VO2max test [Wmax] and with 10% increments) separated by 1.5-minute rest periods (at 20% Wmax).

The program consisted of a 3 minutes warm-up with the first 2 minutes at 20% and last minute at 40% of the TL, followed by 10 series of 1 min duration at 90% of TL, with 1 minute of rest between sets at 20% of TL and ending with 2 minutes of cool-down at 20% of TL (estimated total time of the session: 25 minutes). A 5% increase in workload was applied when, for two consecutive sessions, the first three intervals failed to exceed 85%, and at least five did not reach 90% of maximal HR. Participants were asked to maintain a cadence above 80RPM.

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Vurderede ændringer i oxidativ stress
Tidsramme: Før og efter den 12-ugers intervention
Niveauet af oxidativ stress blev vurderet ved koncentrationen af 8-OHdG som en biomarkør for DNA-oxidation. En kompetitiv ELISA-detektionsmetode blev anvendt i serumprøver. Kort fortalt blev standarden og prøven tilsat en forcoateret mikroplade sammen med den biotinylerede detektionsantistof. Efter vask blev HRP-streptavidin tilsat. Derefter blev TMB-substratet tilsat, og reaktionen blev afsluttet med en syreopløsning. Farveudviklingen blev målt spektrofotometrisk ved en bølgelængde på 450 nm. De optiske densitetsværdier af prøverne blev sammenlignet med dem fra standardkurven for at bestemme 8-OHdG-koncentrationen (ng/ml).
Før og efter den 12-ugers intervention
Muskelbiopsiprøve: Citratsyntaseaktivitet
Tidsramme: Før og efter den 12-ugers intervention
2-5 mg frossen muskelvæv blev homogeniseret i en 1:20 fortynding af CelLytic™ MT Tissue Lysis (C3228, Sigma-Aldrich, Dorset, UK) med 1 % protease inhibitor cocktail (P8340, Sigma-Aldrich, Dorset, UK) ved 4 °C. Lysatet blev centrifugeret ved 12.000 × g i 10 minutter ved 4 °C for at pelletere affald, og supernatantet blev opbevaret ved -80 °C. CS-aktivitet blev kvantificeret i duplikater ved hjælp af et analysekit efter producentens vejledning (CS0720: Sigma-Aldrich, Dorset, UK). Kort fortalt blev endogen aktivitet registreret gennem farveemission fra DTNB, og total aktivitet blev beregnet efter tilsætning af oxalacetat. Proteinkoncentration blev bestemt i duplikater ved hjælp af et bicinchoninsyre-analysekit (BCA1: Sigma-Aldrich, Dorset, UK), hvilket muliggjorde normalisering af CS-aktivitetsværdier til totalt proteinindhold (µmol/g/min). CS-aktivitet og proteinkoncentration blev målt i 96-brænderglasplader ved hjælp af en mikropladelæser ved henholdsvis 412 nm og 562 nm (MQX200R2, Biotek instruments, Burlington, USA).
Før og efter den 12-ugers intervention
Muscle biopsy samples: mitochondrial respiratory capacity
Tidsramme: Pre and post the 12-week intervention

Skin was locally anesthetized, followed by an incision of approximately 6-7mm on the dermal surface. Using sterilized Bergstrom needles, approximately 3-6 mg of skeletal muscle from the lateral vastus were extracted and placed in a BIOPS buffer for immediate analysis of mitochondrial respiration (MR) through high-resolution respirometry. Before, the fibers were mechanically separated in BIOPS buffer using sterilized needles and chemically permeabilized with a 50 μg/ml saponin solution.

MR was measured in a specific buffer (Mir05) in duplicate in hyperoxygenated chambers (250-450 nmol/mL of oxygen) in an Oxygraph-2k at 37ºC (Oroboros, Innsbruck, Austria). A substrate-uncoupler titration protocol was employed by adding (final concentration): malate (2mM), pyruvate (5mM), glutamate (2mM), MgCl2 (3mM), and ADP (5mM), cytochrome C (10μM), succinate (10mM), and p-trifluoromethoxyphenylhydrazone. Oxygen flux was presented as mass-specific (pmol·s/mg wet weight) and normalized to CS activity.

Pre and post the 12-week intervention

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Vurderede ændringer i insulinresistens: HOMA-IR
Tidsramme: Før og efter 12-ugers intervention
Insulinresistens blev estimeret ved hjælp af Homeostatic Model Assessment for Insulin Resistance (HOMA-IR), beregnet som fastende insulin (µU/mL) ganget med fastende glukose (mg/dL) divideret med 405.
Før og efter 12-ugers intervention
Vurderede ændringer i insulinsensitivitet: Matsuda-indeks
Tidsramme: Før og efter 12-ugers intervention
Hele krops insulinfølsomhed blev estimeret gennem Matsuda-indekset, beregnet som 10.000 / √[(fastende glukose (mg/dL) × fastende insulin (µU/mL)) × (gennemsnitlig glukose under Oral Glukose Tolerance Test (mg/dL) × gennemsnitlig insulin under Oral Glukose Tolerance Test (µU/mL))].
Før og efter 12-ugers intervention
Vurderede ændringer i Insulinfølsomhed: Quicki
Tidsramme: Før og efter 12-ugers intervention
Insulinfølsomhed blev estimeret gennem den Kvantitative Insulinfølsomheds Kontrolindeks (QUICKI), beregnet som 1 / [log(fastende insulin (µU/mL)) + log(fastende glukose (mg/dL))].
Før og efter 12-ugers intervention
Vurderede ændringer i Body Mass Index
Tidsramme: Før og efter 12-ugers intervention
Body Mass Index (BMI) i kilogram per kvadratmeter (kg/m²) blev beregnet som kropsvægt (kg) divideret med højden i anden potens (m²).
Før og efter 12-ugers intervention
Vurderede ændringer i antropometri: Omkredse
Tidsramme: Pre og Post 12-ugers intervention
Taljemål (cm) blev målt på midtpunktet mellem den nederste laterale margin af den 10. ribben og iliac-kammen, vinkelret på kroppens længdeakse. Maveomkreds (cm) blev målt på niveau med navlen, vinkelret på kroppens længdeakse. Hofteomkreds (cm) blev målt på niveau med den største posteriore fremspring på ballerne, vinkelret på kroppens længdeakse. Låromkreds (cm) blev målt på midtpunktet mellem trochanter major og den laterale tibia condyle. Alle målinger blev udført med deltageren stående oprejst og afslappet. Hver måling blev foretaget to gange, og en tredje måling blev udført, hvis forskellen oversteg 1%. Gennemsnittet af de to mest ens målinger blev registreret.
Pre og Post 12-ugers intervention
Vurderede ændringer i antropometri: Talje-hofte-forhold
Tidsramme: Før og efter 12-ugers intervention
Talje-hofte-forholdet (WHR) blev beregnet som taljeomkreds (cm) divideret med hofteomkreds (cm).
Før og efter 12-ugers intervention
Vurderet højde
Tidsramme: Før og efter 12-ugers intervention
Højde (meter, m) blev målt ved hjælp af en vægmonteret stadiometer (TANITA-LEICESTER HR-001, Tanita Corp., Tokyo, Japan) med deltagerne stående i henhold til producentens instruktioner.
Før og efter 12-ugers intervention
Assessed changes in Glucose concentration
Tidsramme: Pre and Post the 12-week intervention
Glucose concentration (mg/dL) was measured from blood samples collected from the antecubital vein after at least 8 hours of fasting and at 30, 60, 90, 120, 150, and 180 minutes after the ingestion of 75 grams of glucose (Nuter-tec, 75 g/200 mL, orange flavor). Participants were instructed the day before testing to maintain their usual lifestyle, refrain from alcohol or caffeine consumption for 24 hours, and avoid vigorous physical activity for at least 48 hours. Blood samples were centrifuged and plasma was analyzed using the colorimetric method performed on the Alinity CI system (Abbott Laboratories, Abbott Park, IL, USA).
Pre and Post the 12-week intervention
Assessed changes in Insulin concentration
Tidsramme: Pre and Post the 12-week intervention
Insulin concentration (µU/mL) was measured from blood samples collected from the antecubital vein into serum separator tubes after at least 8 hours of fasting and at 30, 60, 90, 120, 150, and 180 minutes after the ingestion of 75 grams of glucose (Nuter-tec, 75 g/200 mL, orange flavor). Participants were instructed the day before testing to maintain their usual lifestyle, refrain from alcohol or caffeine consumption for 24 hours, and avoid vigorous physical activity for at least 48 hours. Blood samples were centrifuged at 4000 rpm for 7 minutes, and serum was analyzed. Insulin concentrations were determined by chemiluminescent immunoassays performed on the Alinity CI system (Abbott Laboratories, Abbott Park, IL, USA).
Pre and Post the 12-week intervention
Assessed changes in Tissue Oxygenation Index
Tidsramme: Pre and post the 12-week intervention
A NIRO-200NX device was used to measure skeletal muscle tissue oxygenation index (%) through near-infrared spectroscopy (NIRS), the modified Beer-Lambert law (MBLL), and spatially resolved spectroscopy. The NIRS sensor (emitter-sensor distance of 3cm) was placed at two-thirds of the distance from the anterior superior iliac spine to the superolateral patellar border, over the vastus lateralis muscle belly. The NIRS data were continuously acquired throughout a resting energy expenditure test for 30 minutes, a maximal fat oxidation (MFO) test on a cycloergometer, and a maximal oxygen consumption (VO2max) test on a cycloergometer. Briefly, the MFO test consisted of an incremental task with 3-minute phases starting from 15W and increasing by 15W each phase until a respiratory exchange ratio of 1. After a 5-minute rest, the VO2max test was initiated at last MFO load with 15W increases each minute until VO2max determination.
Pre and post the 12-week intervention
Assessed changes in haemoglobin saturation delta
Tidsramme: Pre and post the 12-week intervention
A NIRO-200NX device was used to measure skeletal muscle changes on oxygenated, desoxygenated, and total haemoglobin (μmol/L) through near-infrared spectroscopy (NIRS) and the modified Beer-Lambert law. The NIRS sensor (emitter-sensor distance of 3cm) was placed at two-thirds of the distance from the anterior superior iliac spine to the superolateral patellar border, over the vastus lateralis muscle belly. The NIRS data were continuously acquired throughout a resting energy expenditure test for 30 minutes, a maximal fat oxidation (MFO) test on a cycloergometer, and a maximal oxygen consumption (VO2max) test on a cycloergometer. Briefly, the MFO test consisted of an incremental task with 3-minute phases starting from 15W and increasing by 15W each phase until a respiratory exchange ratio of 1. After a 5-minute rest, the VO2max test was initiated at last MFO load with 15W increases each minute until VO2max determination.
Pre and post the 12-week intervention
Assessed changes in Body Weight
Tidsramme: Pre and Post the 12-week intervention
Body weight (kilograms, kg) was measured using a multifrequency bioelectrical impedance device (TANITA-MC780MA, Tanita Corp., Tokyo, Japan) after at least 8 hours of fasting. Participants were instructed the day before testing to maintain their usual lifestyle, refrain from alcohol or caffeine for 24 hours, and avoid vigorous physical activity for at least 48 hours. Participants wore light clothing and were asked to urinate immediately before the measurement.
Pre and Post the 12-week intervention
Assessed changes in Fat Mass (kilograms of Fat Mass)
Tidsramme: Pre and Post 12-week Intervention
Fat mass (kilograms, kg) was estimated using multifrequency bioelectrical impedance with an 8-electrode device (TANITA-MC780MA, Tanita Corp., Tokyo, Japan) after at least 8 hours of fasting. Participants were instructed the day before testing to maintain their usual lifestyle, refrain from alcohol or caffeine for 24 hours, and avoid vigorous physical activity for at least 48 hours. Participants wore light clothing and were asked to urinate immediately before the measurement.
Pre and Post 12-week Intervention
Assessed changes in Fat Mass (percentage of Fat Mass)
Tidsramme: Pre and Post 12-week Intervention
Fat mass (percentage of total body weight, %) was estimated using multifrequency bioelectrical impedance with an 8-electrode device (TANITA-MC780MA, Tanita Corp., Tokyo, Japan) after at least 8 hours of fasting. Participants were instructed the day before testing to maintain their usual lifestyle, refrain from alcohol or caffeine for 24 hours, and avoid vigorous physical activity for at least 48 hours. Participants wore light clothing and were asked to urinate immediately before the measurement.
Pre and Post 12-week Intervention
Assessed changes in Fat-free Mass (kilograms of Fat-free Mass)
Tidsramme: Pre and Post 12-week Intervention
Fat-free mass (kilograms, kg) was estimated using multifrequency bioelectrical impedance with an 8-electrode device (TANITA-MC780MA, Tanita Corp., Tokyo, Japan) after at least 8 hours of fasting. Participants were instructed the day before testing to maintain their usual lifestyle, refrain from alcohol or caffeine for 24 hours, and avoid vigorous physical activity for at least 48 hours. Participants wore light clothing and were asked to urinate immediately before the measurement.
Pre and Post 12-week Intervention
Assessed changes in Fat-free Mass (percentage of Fat-free Mass)
Tidsramme: Pre and Post 12-week Intervention
Fat-free mass (percentage of total body weight, %) was estimated using multifrequency bioelectrical impedance with an 8-electrode device (TANITA-MC780MA, Tanita Corp., Tokyo, Japan) after at least 8 hours of fasting. Participants were instructed the day before testing to maintain their usual lifestyle, refrain from alcohol or caffeine for 24 hours, and avoid vigorous physical activity for at least 48 hours. Participants wore light clothing and were asked to urinate immediately before the measurement.
Pre and Post 12-week Intervention
Assessed changes in Anthropometry: Skinfold thickness
Tidsramme: Pre and Post 12-week Intervention
Thigh skinfold thickness was measured at two-thirds of the distance from the iliospinale point (the lowest part of the anterior superior iliac spine) to the superolateral border of the patella, over the belly of the vastus lateralis muscle. Measurements were taken on the dominant leg. Two measurements were obtained, and a third was taken if the difference between the first two exceeded 1mm. The mean of the two most similar records was recorded.
Pre and Post 12-week Intervention
Assessed changes in interleukin-6
Tidsramme: Pre and Post the 12-week intervention
Blood drawing was performed with participants in a fasting state for 8-10 hours and scheduled in the morning. Before blood drawing, participants were instructed to maintain their usual lifestyle, avoid alcohol and caffeine for 24 hours, and refrain from vigorous physical activity for at least 48 hours. Blood was collected by peripheral venepuncture using VACUETTE® blood serum separator tubes (Greiner Bio-One, Kremsmünster, Austria). Serum interleukin-6 (pg/mL) was measured by electrochemiluminescence immunoassay using a Cobas e 411 (Roche Diagnostics, Mannheim, Germany).
Pre and Post the 12-week intervention
Assessed changes in C-reactive protein
Tidsramme: Pre and Post the 12-week intervention
Blood drawing was performed with participants in a fasting state for 8-10 hours and scheduled in the morning. Before blood drawing, participants were instructed to maintain their usual lifestyle, avoid alcohol and caffeine for 24 hours, and refrain from vigorous physical activity for at least 48 hours. Blood was collected by peripheral venepuncture using VACUETTE® blood serum separator tubes (Greiner Bio-One, Kremsmünster, Austria). Serum C-reactive protein (mg/L) was determined by immunoturbidimetric assay on the Alinity C analyzer (Abbott Laboratories, Abbott Park, Illinois, USA).
Pre and Post the 12-week intervention
Assessed changes in alanine aminotransferase
Tidsramme: Pre and Post the 12-week intervention
Blood drawing was performed with participants in a fasting state for 8-10 hours and scheduled in the morning. Before blood drawing, participants were instructed to maintain their usual lifestyle, avoid alcohol and caffeine for 24 hours, and refrain from vigorous physical activity for at least 48 hours. Blood was collected by peripheral venepuncture using VACUETTE® blood serum separator tubes (Greiner Bio-One, Kremsmünster, Austria). Serum alanine aminotransferase (U/L) was determined by enzymatic spectrophotometric assays on the Alinity C analyzer (Abbott Laboratories, Abbott Park, Illinois, USA).
Pre and Post the 12-week intervention
Assessed changes in aspartate aminotransferase
Tidsramme: Pre and Post the 12-week intervention
Blood drawing was performed with participants in a fasting state for 8-10 hours and scheduled in the morning. Before blood drawing, participants were instructed to maintain their usual lifestyle, avoid alcohol and caffeine for 24 hours, and refrain from vigorous physical activity for at least 48 hours. Blood was collected by peripheral venepuncture using VACUETTE® blood serum separator tubes (Greiner Bio-One, Kremsmünster, Austria). Serum aspartate aminotransferase (U/L) was determined by enzymatic spectrophotometric assays on the Alinity C analyzer (Abbott Laboratories, Abbott Park, Illinois, USA).
Pre and Post the 12-week intervention
Assessed changes in gamma-glutamyl transferase
Tidsramme: Pre and Post the 12-week intervention
Blood drawing was performed with participants in a fasting state for 8-10 hours and scheduled in the morning. Before blood drawing, participants were instructed to maintain their usual lifestyle, avoid alcohol and caffeine for 24 hours, and refrain from vigorous physical activity for at least 48 hours. Blood was collected by peripheral venepuncture using VACUETTE® blood serum separator tubes (Greiner Bio-One, Kremsmünster, Austria). Serum gamma-glutamyl transferase (U/L) was determined by enzymatic spectrophotometric assays on the Alinity C analyzer (Abbott Laboratories, Abbott Park, Illinois, USA).
Pre and Post the 12-week intervention
Assessed changes in tumor necrosis factor-alpha
Tidsramme: Pre and Post the 12-week intervention
Blood drawing was performed with participants in a fasting state for 8-10 hours and scheduled in the morning. Before blood drawing, participants were instructed to maintain their usual lifestyle, avoid alcohol and caffeine for 24 hours, and refrain from vigorous physical activity for at least 48 hours. Blood was collected by peripheral venepuncture using VACUETTE® EDTA K2 separator tubes (Greiner Bio-One, Kremsmünster, Austria) to obtain plasma. Plasma was aliquoted into 500 µL tubes with 5 µL protease inhibitors, then stored at -80 °C. Plasma tumor necrosis factor-alpha (pg/mL) was measured using multiplex magnetic bead-based immunoassays (MILLIPLEX® Metabolic Hormone Panel V3, HMH3-34K-06, Merck Millipore, Darmstadt, Germany) and analyzed with a Luminex® xMap IntelliFlex System (Luminex Corp., Austin, TX, USA).
Pre and Post the 12-week intervention
Assessed changes in triglycerides
Tidsramme: Pre and Post the 12-week intervention
Blood drawing was performed with participants in a fasting state for 8-10 hours and scheduled in the morning. Before blood drawing, participants were instructed to maintain their usual lifestyle, avoid alcohol and caffeine for 24 hours, and refrain from vigorous physical activity for at least 48 hours. Blood was collected by peripheral venepuncture using VACUETTE® blood serum separator tubes (Greiner Bio-One, Kremsmünster, Austria). Serum triglycerides (mg/dL) was determined by enzymatic spectrophotometric assays on the Alinity C analyzer (Abbott Laboratories, Abbott Park, Illinois, USA).
Pre and Post the 12-week intervention
Assessed changes in total cholesterol
Tidsramme: Pre and Post the 12-week intervention
Blood drawing was performed with participants in a fasting state for 8-10 hours and scheduled in the morning. Before blood drawing, participants were instructed to maintain their usual lifestyle, avoid alcohol and caffeine for 24 hours, and refrain from vigorous physical activity for at least 48 hours. Blood was collected by peripheral venepuncture using VACUETTE® blood serum separator tubes (Greiner Bio-One, Kremsmünster, Austria). Serum total cholesterol (mg/dL) was determined by enzymatic spectrophotometric assays on the Alinity C analyzer (Abbott Laboratories, Abbott Park, Illinois, USA).
Pre and Post the 12-week intervention
Assessed changes in high-density lipoprotein
Tidsramme: Pre and Post the 12-week intervention
Blood drawing was performed with participants in a fasting state for 8-10 hours and scheduled in the morning. Before blood drawing, participants were instructed to maintain their usual lifestyle, avoid alcohol and caffeine for 24 hours, and refrain from vigorous physical activity for at least 48 hours. Blood was collected by peripheral venepuncture using VACUETTE® blood serum separator tubes (Greiner Bio-One, Kremsmünster, Austria). Serum high-density lipoprotein (mg/dL) was determined by enzymatic spectrophotometric assays on the Alinity C analyzer (Abbott Laboratories, Abbott Park, Illinois, USA).
Pre and Post the 12-week intervention
Assessed changes in low-density lipoprotein
Tidsramme: Pre and Post the 12-week intervention
Blood drawing was performed with participants in a fasting state for 8-10 hours and scheduled in the morning. Before blood drawing, participants were instructed to maintain their usual lifestyle, avoid alcohol and caffeine for 24 hours, and refrain from vigorous physical activity for at least 48 hours. Blood was collected by peripheral venepuncture using VACUETTE® blood serum separator tubes (Greiner Bio-One, Kremsmünster, Austria). Serum low-density lipoprotein (mg/dL) was determined by enzymatic spectrophotometric assays on the Alinity C analyzer (Abbott Laboratories, Abbott Park, Illinois, USA).
Pre and Post the 12-week intervention

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Efterforskere

  • Ledende efterforsker: Cristina Casals Vázquez, PhD, University of Cadiz
  • Ledende efterforsker: Miguel Efrén Jiménez Romero, MD, Hospital de la Línea de la Concepción

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

10. marts 2022

Primær færdiggørelse (Faktiske)

31. december 2025

Studieafslutning (Faktiske)

31. december 2025

Datoer for studieregistrering

Først indsendt

26. september 2025

Først indsendt, der opfyldte QC-kriterier

18. november 2025

Først opslået (Faktiske)

26. november 2025

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

15. september 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

10. september 2026

Sidst verificeret

1. september 2026

Mere information

Begreber relateret til denne undersøgelse

Andre undersøgelses-id-numre

  • MITOX
  • PP11-007-2023 (Andet bevillings-/finansieringsnummer: Instituto de Investigación e Innovación Biomédica de Cádiz)

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

INGEN

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Abonner